APYX vs RUN · rev $48.1M vs P/E 6.0, rev $2.04B
Apyx Medical Inc (APYX) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
APYX currently screens at market cap $179.6M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the APYX and RUN stock pages for the full models.
Not investment advice.